These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10505421

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart.
    Edes I, Kiss E, Kitada Y, Powers FM, Papp JG, Kranias EG, Solaro RJ.
    Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868
    [Abstract] [Full Text] [Related]

  • 3. Effect of levosimendan on balance between ATP production and consumption in isolated perfused guinea-pig heart before ischemia or after reperfusion.
    Eriksson O, Pollesello P, Haikala H.
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):316-21. PubMed ID: 15475828
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. ORM-3819 promotes cardiac contractility through Ca(2+) sensitization in combination with selective PDE III inhibition, a novel approach to inotropy.
    Nagy L, Pollesello P, Haikala H, Végh Á, Sorsa T, Levijoki J, Szilágyi S, Édes I, Tóth A, Papp Z, Papp JG.
    Eur J Pharmacol; 2016 Mar 15; 775():120-9. PubMed ID: 26872993
    [Abstract] [Full Text] [Related]

  • 9. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure?
    Zimmermann N, Boknik P, Gams E, Herzig JW, Neumann J, Scholz H.
    Eur J Cardiothorac Surg; 1998 Jul 15; 14(1):70-5. PubMed ID: 9726618
    [Abstract] [Full Text] [Related]

  • 10. Effects of levosimendan on myocardial contractility and Ca2+ transients in aequorin-loaded right-ventricular papillary muscles and indo-1-loaded single ventricular cardiomyocytes of the rabbit.
    Sato S, Talukder MA, Sugawara H, Sawada H, Endoh M.
    J Mol Cell Cardiol; 1998 Jun 15; 30(6):1115-28. PubMed ID: 9689586
    [Abstract] [Full Text] [Related]

  • 11. Effects of Combined Milrinone and Levosimendan Treatment on Systolic and Diastolic Function During Postischemic Myocardial Dysfunction in a Porcine Model.
    Axelsson B, Häggmark S, Svenmarker S, Johansson G, Gupta A, Tydén H, Wouters P, Haney M.
    J Cardiovasc Pharmacol Ther; 2016 Sep 15; 21(5):495-503. PubMed ID: 26837238
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration, and left ventricular function.
    Kristof E, Szigeti G, Papp Z, Bodi A, Facsko A, Kovacs L, Papp JG, Kranias EG, Edes I.
    Ann N Y Acad Sci; 1998 Sep 16; 853():316-9. PubMed ID: 10603968
    [No Abstract] [Full Text] [Related]

  • 15. Ca2+ sensitizer superior to catecholamine during myocardial stunning?
    Meyer K, Klocke RC, Schipke JD, Gams E, Korbmacher B.
    Eur J Cardiothorac Surg; 2008 Aug 16; 34(2):326-31. PubMed ID: 18539040
    [Abstract] [Full Text] [Related]

  • 16. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts.
    Rump AF, Acar D, Klaus W.
    Br J Pharmacol; 1994 Jul 16; 112(3):757-62. PubMed ID: 7921599
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart.
    du Toit EF, Genis A, Opie LH, Pollesello P, Lochner A.
    Br J Pharmacol; 2008 May 16; 154(1):41-50. PubMed ID: 18297097
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.